Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Center for Vaccine Development
685 W. Baltimore Street, suite 480
Baltimore, MD 21201Phone+1 410-706-5328Fax+1 410-706-6205- Is this information wrong?
Summary
- Dr. Wilbur Chen is the Frank M. Calia, MD Endowed Professor of Medicine, an infectious disease physician-scientist at the University of Maryland School of Medicine, affiliated with the University of Maryland Medical Center. He received his medical degree from Howard University College of Medicine and has been in practice 18 years. He specializes in international health, travel & tropical and is the Director of the University of Maryland, Baltimore Travel Medicine Practice. He conducts vaccine research on diarrheal diseases, influenza, and tropical medicine.
Education & Training
- University of Maryland School of MedicineMS, Clinical Research, 2004 - 2008
- University of Maryland School of MedicinePost-Doctoral Fellowship, NIH T32 Vaccinology, 2004 - 2006
- University of MarylandFellowship, Infectious Disease, 2002 - 2004
- Johns Hopkins UniversityResidency, Internal Medicine, 1999 - 2002
- Howard University College of MedicineClass of 1999
Certifications & Licensure
- MD State Medical License 2004 - 2024
Clinical Trials
- H5N1 (Clade 2) Vaccination of Adults and Elderly Start of enrollment: 2008 Nov 01
- Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59 Start of enrollment: 2010 Jun 01
- Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations Start of enrollment: 2009 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023.Marco Cavaleri, David Kaslow, Eric Boateng, Wilbur H Chen, Christopher Chiu, Robert K M Choy, Rodrigo Correa-Oliveira, Anna Durbin, Moses Egesa, Malick Gibani, Melissa...> ;Biologicals. 2024 Feb 1
- 7 citationsEnhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyond.Hyung-Joon Kwon, Martina Kosikova, Weichun Tang, Uriel Ortega-Rodriguez, Peter Radvak, Ruoxuan Xiang, Kelly E Mercer, Levan Muskhelishvili, Kelly Davis, Jerrold M Ward...> ;Iscience. 2022 Dec 22
- 6 citationsThe antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination.Johannes B Goll, Aarti Jain, Travis L Jensen, Rafael Assis, Rie Nakajima, Algis Jasinskas, Lynda Coughlan, Sami R Cherikh, Casey E Gelber, S Khan, D Huw Davies, Philip...> ;NPJ Vaccines. 2022 Aug 30
- Join now to see all
Journal Articles
- Responses of the Human Gut Escherichia Coli Population to Pathogen and Antibiotic DisturbancesWilbur Chen, MD, mBio
Press Mentions
- Incredible Medical Advances of 2022December 23rd, 2022
- Vaccines for RSV, the Illness That's Been Sickening Babies Across the US, Are Poised to Become Available in 2023November 11th, 2022
- Strong RSV Vaccine Data Lifts Hopes After Years of FutilityNovember 2nd, 2022
- Join now to see all
Grant Support
- Clinical Trial: Phase I/II Study Of A Booster Dose Of A/H5n1/Indonesia/05/05 (ClNational Center For Research Resources2009
Professional Memberships
- Member
- American Society of Tropical Medicine and HygieneMember
- American Society for MicrobiologyMember
- Infectious Diseases Society of AmericaMember
Hospital Affiliations
- Veterans Affairs Maryland Health Care System-Baltimore DivisionBaltimore, Maryland
- University of Maryland Medical CenterBaltimore, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: